EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IL15.3, a synthetic antimicrobial peptide, attenuates LPS-induced inflammatory responses in RAW 264.7 macrophages via transcriptional and proteomic modulation

Chanapat Boonmark, Sittiruk Roytrakul, Fasawanya Saengyotha, Anupong Tankrathok iD, Anuwat Wanthong, Jureerut Daduang, Sakda Daduang, Arunrat Chaveerach, Nisachon Jangpromma iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0361031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Chanapat Boonmark und 8 weiteren Autor:innen. Beteiligte Einrichtung: Protein and Bio-Innovation Research Center for Sustainable Health (ProBISH), Faculty of Science, Khon Kaen University, Khon Kaen, Thailand. Hauptthemen laut MEDLINE: Lipopolysaccharides, Macrophages, Antimicrobial Peptides, Inflammation. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Fund of Khon Kaen University, the National Science, Research and Innovation Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation underlies numerous pathological conditions, driving the need for safe and effective anti-inflammatory agents. Anti-inflammatory peptides (AIPs) are promising therapeutics due to their specificity, efficacy, and safety. This study evaluated the cationic antimicrobial peptide IL15.3 for anti-inflammatory activity and cytocompatibility in vitro . IL15.3 demonstrated low cytotoxicity in MTT assays using RAW 264.7 macrophages, normal human dermal fibroblasts (NHDF), and HaCaT keratinocytes. In LPS-stimulated RAW 264.7 cells, IL15.3 significantly reduced nitric oxide (NO) production and reactive oxygen species (ROS) in a dose-dependent manner without affecting cell viability. qRT-PCR analysis revealed significant suppression of iNOS , COX-2 , TNF-α , and IL-6 mRNA expression, alongside downregulation of NF-κB , JNK , STAT1 , and STAT3 , and a reciprocal shift in Keap1 / Nrf2 expression suggestive of possible antioxidant pathway activation. Label-free proteomic profiling identified 5,191 proteins, revealing a multi-modal mechanism of action. IL15.3 treatment exclusively induced 4 anti-inflammatory proteins (ISG15, PEX14, TNIP3, PR) and upregulated negative regulators NRG1, DAB2IP, IL-18BP and SOCS5. Critically, IL15.3 suppressed key pro-inflammatory mediators including IKKβ, JAK1, JAK3, JNK, and IL-1RAcP, demonstrating comprehensive modulation of NF-κB, JAK/STAT, and MAPK pathways. In silico molecular docking further predicted potential interactions of IL15.3 with iNOS and the Keap1 Kelch domain, offering preliminary structural insight consistent with its putative dual anti-inflammatory and antioxidant activity. Together, these findings indicate that IL15.3 exhibits potent anti-inflammatory and antioxidant activity through multiple mechanisms in LPS-stimulated macrophages at transcriptional and proteomic levels. The coordinated upregulation of negative regulators and suppression of central inflammatory mediators collectively suggest that IL15.3 may represent a promising therapeutic candidate for inflammatory disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LipopolysaccharidesMacrophagesAntimicrobial PeptidesInflammationAnti-Inflammatory AgentsTranscription, GeneticAnimalsMiceHumansRAW 264.7 CellsProteomicsReactive Oxygen SpeciesNitric OxideKeratinocytesCell LineGene Expression Regulation

Substanzen

LipopolysaccharidesReactive Oxygen SpeciesAntimicrobial PeptidesAnti-Inflammatory AgentsNitric Oxide

Autor:innen und Institutionen

  • Protein and Bio-Innovation Research Center for Sustainable Health (ProBISH), Faculty of Science, Khon Kaen University, Khon Kaen, Thailand.
  • National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Pathumthani, Thailand.
  • Faculty of Agricultural Technology, Department of Biotechnology, Kalasin University, Kalasin, Thailand.
  • Department of Biology, Faculty of Science, Mahasarakham University, Mahasarakham, Thailand.
  • Department of Clinical Chemistry, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.
  • Department of Pharmacognosy and Toxicology, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand.

ORCID-Profile: Anupong Tankrathok, Nisachon Jangpromma

Förderung

  • Fundamental Fund of Khon Kaen University, the National Science, Research and Innovation Fund

Zitieren

APA

Boonmark, C., Roytrakul, S., Saengyotha, F., Tankrathok, A., Wanthong, A., Daduang, J., Daduang, S., Chaveerach, A., & Jangpromma, N. (2026). IL15.3, a synthetic antimicrobial peptide, attenuates LPS-induced inflammatory responses in RAW 264.7 macrophages via transcriptional and proteomic modulation. PLOS One. https://doi.org/10.1371/journal.pone.0361031

Vancouver

Boonmark C, Roytrakul S, Saengyotha F, Tankrathok A, Wanthong A, Daduang J, et al. IL15.3, a synthetic antimicrobial peptide, attenuates LPS-induced inflammatory responses in RAW 264.7 macrophages via transcriptional and proteomic modulation. PLOS One. 2026. doi:10.1371/journal.pone.0361031

BibTeX
@article{Boonmark2026,
  author = {Boonmark, Chanapat and Roytrakul, Sittiruk and Saengyotha, Fasawanya and Tankrathok, Anupong and Wanthong, Anuwat and Daduang, Jureerut and Daduang, Sakda and Chaveerach, Arunrat and Jangpromma, Nisachon},
  title = {IL15.3, a synthetic antimicrobial peptide, attenuates LPS-induced inflammatory responses in RAW 264.7 macrophages via transcriptional and proteomic modulation},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0361031}
}
Kostenlos starten →